Abstract:Activation or inactivation of members of the cyclin-dependent kinase family is important during cell cycle progression. However, Cdk5, a member of this family that was originally identified because of its high structural homology to Cdc2, is activated during cell differentiation and cell death but not during cell cycle progression. We previously demonstrated a correlation between the up-regulation of Cdk5 protein and kinase activity and cell death during development and pathogenesis. We report here that cyclophosphamide (CP) induces massive apoptotic cell death in mouse embryos and that Cdk5 is expressed in apoptotic cells displaying fragmented DNA. During CP-induced cell death, Cdk5 protein expression is substantially increased as detected by immunohistochemistry but not by Western blot, while its mRNA level remains the same as control, and its kinase activity is markedly elevated. The up-regulation of Cdk5 during CP-induced cell death is not due to de novo protein synthesis. We also examined p35, a regulatory protein of Cdk5 in neuronal differentiation. Using a yeast two-hybrid system, we isolated p35, a neuronal differentiation specific protein, as a protein that interacts with Cdk5 in CP-treated embryos. p35 mRNA level does not change, but the protein expression of p25, a truncated form of p35, is elevated during cell death in vivo, as established here, as well as during cell death in vitro. Our results suggest a role for Cdk5 and its regulatory proteins during CP induced cell death. These results further support the view that Cdk5 and its regulation may be key players in the execution of cell death regardless of how the cell dies, whether through biological mechanisms, disease states such as Alzheimer's disease, or induction by CP.

Nuclear Translocation of PDCD5 (TFAR19): an Early Signal for Apoptosis?

PDCD5 (programmed Cell Death 5)

Nuclear Translocation of Apoptosis-Related Protein TFAR19 in TF-1 Cells Undergoing Apoptosis

Cellular functions of programmed cell death 5.

Cellular Uptake of Exogenous Human PDCD5 Protein

Cyclin Dependent Kinase 5 and Its Interacting Proteins in Cell Death Induced in Vivo by Cyclophosphamide in Developing Mouse Embryos

Structure-Function Correlation of Human Programmed Cell Death 5 Protein

Pdcd5-Regulated Cell Fate Decision after Ultraviolet-Irradiation-Induced Dna Damage

[Expression of TFAR19(PDCD5) in Normal Human Kidney, Renal Clear Cell Carcinoma, Normal Human Bladder and Bladder Carcinoma].

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

Short Interfering RNA Against the PDCD5 Attenuates Cell Apoptosis and Caspase-3 Activity Induced by Bax Overexpression

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

The Clinical Significance of Reduced Programmed Cell Death 5 Expression in Human Gastrointestinal Stromal Tumors.

The N-terminal 26-Residue Fragment of Human Programmed Cell Death 5 Protein Can Form a Stable Alpha-Helix Having Unique Electrostatic Potential Character.

The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide.

Nuclear Localization of C-Flip-l and Its Regulation of AP-1 Activity

Expression of Programmed Cell Death 5 Gene Involves in Regulation of Apoptosis in Gastric Tumor Cells

An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression.

[Abnormal Expression of PDCD5 in the Bone Marrow Cells of Adult Acute Myeloid Leukemia].